Dust Extraction System in Pharmaceutical Industry: Key Rules

Una dust extraction system in the pharmaceutical industry must do more than move air: it has to contain potent powders at the source, stop one product’s dust from reaching another, survive repeated cleaning, and manage combustible-dust risk. Those four requirements, not airflow alone, should drive equipment selection and duct design.

Why Pharmaceutical Dust Extraction Follows Different Rules

In woodworking or metal fabrication, a dust collector is judged mostly on capture velocity, filtration efficiency and how much housekeeping it saves. Those measures still apply in a pharmaceutical plant. They are just the starting point.

Four constraints change the design:

1. Containment. Many active pharmaceutical ingredients (APIs) act at very small doses. The extraction system becomes part of the operator-exposure control strategy, so every place where dust can escape needs a defined control: the hood, each duct joint, the filter housing and the discharge point.
2. Cross-contamination. A shared duct network physically connects rooms. If airflow reverses or a damper leaks, dust from one product can settle in a room processing another. GMP frameworks treat that as a product-quality failure, not a housekeeping issue.
3. Cleanability. Equipment in or near production areas is cleaned on a schedule. Ledges, crevices and rough internal welds that hold powder turn into cleaning-validation problems.
4. Combustibility. Many excipients and APIs are organic powders. Fine organic dust can be explosible, and a collector concentrates it in one enclosed volume.

A system that handles the first three but ignores the fourth is unsafe. One that handles explosion risk but leaks between suites is non-compliant.

Rule 1: Classify the Powder Before You Size the Fan

Airflow numbers come last. The powder data comes first, because it decides the capture method, the filter arrangement and the explosion-protection concept.

If combustibility data does not exist, do not assume the powder is safe. NFPA 660 (Standard for Combustible Dusts and Particulate Solids, 2025 Edition) consolidates NFPA’s requirements for combustible-dust hazards, including dust hazard analysis. OSHA’s combustible dust resources cover the U.S. general-industry hazards that apply to dust collectors and powder handling.

Capture at the Source, Not the Room

General room exhaust dilutes dust after it has already reached the operator’s breathing zone. Pharmaceutical extraction should capture as close to the emission point as the process allows. Typical points include dispensing booths, sieving and milling stations, granulator charging, tablet press and capsule filler exhaust, coating pan exhaust and drum or IBC charging.
Two details are easy to miss:
Weighing stations are an edge case. Strong capture velocity near an analytical balance makes readings drift. Dispensing hoods and downflow booths are designed to balance capture against weighing stability, so their extraction volume should come from the booth supplier’s specification rather than a generic hood formula.
Extraction changes room pressure. Pharmaceutical suites usually run a pressure cascade between rooms and corridors. Every cubic meter the extraction system removes has to be replaced by the HVAC system. When an extraction branch opens or closes, room pressure shifts. The extraction controls and the HVAC controls need to be designed together, with branch valve states included in the pressure-balance calculation.

How Do You Keep One Product’s Dust Out of Another Product’s Room?

The first decision is architectural: dedicated extraction per suite or line, or one shared system with isolation.
Dedicated units remove the shared duct path entirely. They cost more in equipment count and floor or technical-area space, but changeover cleaning is contained to one line, and a fault in one unit affects one suite.
A shared system can be acceptable for low-hazard products, provided the duct network is designed against backflow and settling:

1. Fit non-return dampers or automatic shut-off valves on each branch so idle rooms are isolated.
2. Keep transport velocity high enough in every branch, including partially closed ones, that dust stays airborne to the collector.
3. Minimize long horizontal runs where powder can settle; where unavoidable, add access points for inspection and cleaning.
4. Consider pre-filtration close to the source for potent compounds, so the main duct carries less active material.
5. Re-check room pressures with every combination of open and closed branches.

For highly potent compounds, dedicated extraction is the usual starting point, and a shared system needs a documented justification.

General Industrial vs. Pharmaceutical Extraction: What Actually Changes

Compared with the large centralized systems commonly used in woodworking or metal fabrication, pharmaceutical extraction trades scale for control.

Cleanability: Design Details That Decide Cleaning Validation

Cleaning validation fails on geometry more often than on chemistry. Before approving a collector or duct layout, look at it the way a cleaning operator will:

• Internal surfaces should be smooth, with welds that do not leave pockets.
• Horizontal ledges inside housings and hoppers should be avoided or sloped.
• Inspection doors should be large enough to reach every internal surface that powder touches.
• Gaskets and seals must tolerate the cleaning agents and disinfectants actually used on site.
• Material grade and surface finish for components located in process areas should be specified in the purchase documents, not left to the supplier’s default.

Discharge deserves its own review. A drawer or open bin that an operator empties by hand undoes the containment provided upstream. A closed discharge into a sealed liner or container keeps the collected powder enclosed until disposal.

The Filter Change Is the Highest-Exposure Moment

A common assumption is that a high-efficiency filter makes the system contained. During normal operation it does. When a loaded cartridge is pulled out of its housing, the operator is standing next to the most concentrated dust in the plant.
Practical controls include:

• Safe-change (bag-in/bag-out) housings, where the filter is removed into a sealed bag without opening the housing to the room.
• A cleaning cycle before the change, so the cartridge carries less loose dust.
• Differential-pressure monitoring, so changes are planned rather than triggered by a failure mid-batch.
• Defined PPE and a written procedure for the change, matched to the exposure band of the powder.

Where the Senserui S Series Fits, and Where It Doesn’t

The Senserui S Series Dust Control Mainframe is a compact unit designed for fine and ultrafine particulate. Pharmaceutical manufacturing is listed among its target applications, alongside battery materials and electronics.

Where it fits: the airflow range suits a single suite, line or group of related emission points. That makes it a candidate for the dedicated-unit approach described above, where each line gets its own collector rather than sharing a central system. Its fine-dust orientation and sensor monitoring match the needs of powder-handling areas.
Where to be careful: the published S Series data does not state the material grade or surface finish of internal parts, whether a safe-change filter housing is available, the dust discharge method, or what qualification documentation is supplied. For a GMP project, request these in writing before shortlisting. The 15,000 m³/h upper limit also means larger multi-line facilities will need several units, or a larger series such as the CP Series (30,000–150,000 m³/h, designed for fine dust) for non-potent applications where a shared system is acceptable. At up to 6,000 mm tall, outdoor or technical-area placement for explosion venting needs to be planned in the site layout.
Senserui performs in-house airflow, noise and filter testing and factory inspection before delivery. Ask how those test records can support your factory acceptance testing.Specification Checklist: 7 Steps Before You Request Quotes

• Collect the powder data. Exposure band, combustibility test results, particle size and handling behaviour for every product. Done when: each product has a completed data sheet, or a documented decision to treat unknown data conservatively.
• Map every emission point. List each process step and assign a capture method (isolator, booth, enclosed hood, local hood). Done when: the list covers dispensing through packaging, with no “general room extraction” placeholders.
• Choose dedicated or shared extraction. Base the choice on potency and product mix. Done when: the decision and its justification are written into the design basis.
• Calculate airflow and duct velocities. Size each hood from its supplier’s data and check transport velocity in every branch with others closed. Done when: calculations exist for every valve combination you expect in operation.
• Coordinate with HVAC. Confirm room pressure differentials hold with the extraction running, idle and in transition. Done when: HVAC and extraction designers have signed off on a shared pressure-balance calculation.
• Specify cleaning, filter change and discharge. Material grade, finish, gasket compatibility, safe-change requirement and closed discharge. Done when: each item appears in the purchase specification with a measurable requirement.
• Complete the hazard review and documentation plan. Dust hazard analysis, equipment zoning, collector location, and the documents needed for qualification. Done when: the vendor has confirmed in writing which documents and tests it will provide.

FAQ Can a general industrial dust collector be used in a pharmaceutical plant?For low-hazard, non-product-contact applications it sometimes can, but it usually needs changes: branch isolation, closed discharge, cleanable internals, and an explosion-protection concept matched to the powder. For potent APIs, containment requirements generally rule out standard open-discharge designs.Should each pharmaceutical suite have its own dust collector?Dedicated units remove the shared duct path that causes cross-contamination, so they are the usual choice for potent compounds or frequent product changeovers. Shared systems can work for low-hazard products if backflow prevention and duct velocities are designed and documented. Are pharmaceutical powders a combustible dust risk?Many are, because a large share of excipients and APIs are organic. Only testing confirms it for a specific powder. NFPA 660 and the EU ATEX framework (Directive 2014/34/EU) are the main references for assessing and controlling the hazard.How often should filters be changed?There is no fixed interval. Use differential-pressure monitoring to track filter loading, and schedule changes between batches using a written procedure suited to the powder’s exposure band. What airflow does the Senserui S Series cover?The S Series spans 3,000–15,000 m³/h across models S3 to S15, with rated power of 3–15 kW. Configuration for a specific line depends on the number of capture points and their required airflow.